Integrated Team Approach Dramatically Improves Survival in Complex Fetal Congenital Heart Disease, study finds

Could a team-based perinatal approach be the key to better outcomes in complex fetal congenital heart disease (CHD)? For clinicians, managing pregnancies complicated by complex CHD often means facing tough decisions about timing of delivery, mode of birth, and immediate newborn care. A new retrospective study published in BMC Pregnancy and Childbirth sheds light on how integrated, multidisciplinary care can optimize outcomes for these high-risk cases.

Study Design: Retrospective Review of Integrated Management

Researchers analyzed data from 123 pregnancies diagnosed with complex fetal CHD by prenatal ultrasound at a major Chinese academic center between 2016 and 2023. The study focused on how a coordinated approach—bringing together obstetricians, pediatric cardiac surgeons, neonatologists, and sonographers—impacted perinatal management and neonatal outcomes.

Complex CHD included severe lesions such as transposition of the great arteries (TGA), total anomalous pulmonary venous connection (TAPVC), double outlet right ventricle (DORV), and others. All cases were managed with pre-delivery counseling, close fetal surveillance, and proactive planning for delivery and postnatal cardiac intervention.

Key Findings: Timing, Delivery, and Postnatal Care

Timing Matters: Avoiding preterm birth whenever possible was associated with better neonatal outcomes. Deliveries at or beyond 39 weeks had zero cases of poor prognosis, while earlier deliveries saw higher risks.

Delivery Mode: Despite high overall cesarean rates in China, the study found that complex CHD alone does not indicate a need for cesarean delivery. Most fetuses tolerated labor well, with comparable rates of intrapartum distress and neonatal asphyxia to the general population. The mode of delivery was best guided by standard obstetric indications and patient preference.

Immediate Postnatal Management: Nearly 70% of newborns with complex CHD required prostaglandin (alprostadil) infusion to maintain ductal patency, which significantly improved oxygen saturation. Prompt transfer to pediatric cardiac surgery centers was essential, and over 98% of neonates who underwent surgical intervention had favorable outcomes.

Clinical Implications: Why These Findings Matter

For clinicians, this study reinforces that multidisciplinary, integrated management—beginning with accurate prenatal diagnosis and continuing through delivery and neonatal care—can improve survival and prognosis in complex fetal CHD. The findings suggest that:

Scheduled delivery at or after 39 weeks is ideal when maternal and fetal status are stable.

Cesarean delivery should be reserved for standard indications, not simply due to the presence of complex CHD.

Coordinated planning ensures timely stabilization and surgical referral, reducing perioperative risks.

Defining Terms: Complex CHD and Ductal Patency

Complex CHD: Refers to severe structural heart defects involving multiple chambers or vessels, requiring urgent and specialized intervention after birth.

Ductal Patency: Keeping the ductus arteriosus open with medication (like prostaglandin) is often critical for oxygen delivery in neonates with certain heart defects.

Limitations and Future Directions

As a single-center, retrospective study, the results may not be generalizable to all settings. Larger, multicenter studies with longer follow-up are needed to confirm these findings and fine-tune best practices.

Conclusion

A coordinated, multidisciplinary approach to pregnancies complicated by complex fetal CHD can make a significant difference. By individualizing delivery plans and ensuring rapid postnatal intervention, clinicians can help most affected newborns achieve excellent outcomes.

Key points

Integrated, multidisciplinary care improves outcomes for pregnancies with complex fetal CHD.

Delivery should be planned at or after 39 weeks when possible, avoiding unnecessary preterm birth.

Complex CHD alone is not a reason for cesarean; standard obstetric criteria should guide delivery mode.

Prostaglandin therapy post-birth is often lifesaving for maintaining ductal patency.

Over 98% of neonates receiving timely surgical care had favorable outcomes.

Citation:

Junshu X., Fufen Y., Xiuju Y. et al. Integrated pregnancy and perinatal management of complex fetal congenital heart disease: a preliminary retrospective study. BMC Pregnancy Childbirth. 2026; https://doi.org/10.1186/s12884-026-09616-x